Is United Therapeutics Corporation (UTHR) a Buy, Sell, or Hold?
NASDAQ : UTHR
United Therapeutics Corporation — Analyst Ratings
$517.71 USD
-$8.11 (-1.54%)
- Volume
- 396.51K
- Average Volume
- 486.23K
- Market Capitalization
- $21.98B
- P/E Ratio
- 17.69
- Dividend Yield
- 0.00%
- Price Target
- $625.00
- Year High
- $609.35
- Year Low
- $287.65
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.79
Analyst Consensus Summary
Consensus Rating
Buy
30 Analysts
Rating Score
4/5
Recommendation Strength
Upside/Downside
-17.2%
vs Current Price
Price Target
$625.00
Average TargetPrice Target Range
Lowest Target
$516.00
0.3% UPSIDE
Average Target
$625.00
Median Estimate
Highest Target
$735.00
-29.6% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 30
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 17 | 12 | 1 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Morgan Stanley | Terence Flynn | $516 | $583.145 | 2026-05-07 09:29 AM | -11.5% |
| Morgan Stanley | Terence Flynn | $519 | $570.48 | 2026-04-10 08:54 AM | -9.0% |
| Cantor Fitzgerald | Olivia Brayer | $625 | $541.6041 | 2026-03-12 09:11 AM | 15.4% |
| H.C. Wainwright | Andrew Fein | $600 | $508.4749 | 2026-02-26 12:23 PM | 18.0% |
| Jefferies | Eun Yang | $575 | $476.59 | 2025-11-19 04:24 AM | 20.6% |
| H.C. Wainwright | Andrew Fein | $525 | $449.76 | 2025-10-30 09:34 AM | 16.7% |